Related Experiment Video
Updated: Jun 18, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Capturing the Value of Vaccination within Health Technology Assessment and Health Economics-Practical Considerations
Eliana Biundo1, Mariia Dronova2, Annie Chicoye3
1GSK, Building W23, 20 Avenue Fleming, 1300 Wavre, Belgium.
This study expands the value of vaccination (VoV) framework to include health systems strengthening, equity, and macroeconomic gains in cost-effectiveness analysis (CEA). Incorporating these broader benefits provides more accurate VoV assessments for decision-makers.
Area of Science:
- Health Economics
- Public Health Policy
- Vaccine Research
Background:
- The value of vaccination (VoV) framework is crucial for health technology assessment (HTA) and cost-effectiveness analysis (CEA).
- Previous frameworks identified key vaccination benefits for HTA/CEA, but broader impacts require further integration.
- Decision-makers need comprehensive methods to assess the full value of vaccination programs.
Purpose of the Study:
- To provide methods and examples for incorporating health systems strengthening (HSS), equity, and macroeconomic gains into VoV assessments.
- To demonstrate how these broader benefits influence the incremental cost-effectiveness ratio (ICER) in vaccination HTA/CEA.
- To enhance the accuracy and completeness of VoV assessments for improved decision-making.
Main Methods:
- Application of expert working groups and targeted literature reviews.
- Utilized opportunity cost methods for HSS benefits of rotavirus vaccination.
- Employed distributional CEA for health equity benefits of meningococcal vaccination and macroeconomic modeling for wider economic impacts.
Main Results:
- Including HSS benefits reduced the ICER for rotavirus vaccination by 1.4-50.5%.
- Including equity benefits for meningococcal vaccination reduced the ICER by 22-56%, with significant gains in deprived groups.
- Macroeconomic models can inform HTA processes by assessing impacts on labor force and wider economy.
Conclusions:
- Broader vaccination benefits, including HSS, equity, and macroeconomic gains, can be assessed and integrated into current HTA/CEA.
- These integrated assessments lead to more accurate and complete VoV evaluations.
- Further refinement of methods and inputs, particularly for macroeconomic gains, is recommended.
Related Concept Videos
Vaccinations
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Health Information Technology and Healthcare Information System
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...

